abstract |
The present invention relates to compounds useful in the positive modulation of the alpha 7 nicotinic acetylcholine receptor (alpha7nAChR). The invention also relates to the use of these compounds in the treatment or prevention of a broad range of diseases in which the positive modulation of alpha7nAChR is advantageous, including neurodegenerative and neuropsychiatric diseases and also inflammatory diseases. |